Hydrocodone-Acetaminophen — Discount Pricing

Other medications in Pain & Inflammation

• Hydromorphone
• Ibuprofen
• Ketoprofen Gel
• Ketorolac
• Meclofenamate
• Menthol-Methyl Salicylate
• Meperidine
• Metaxalone

About Hydrocodone-Acetaminophen

Hydrocodone acetaminophen is a commonly prescribed medication used to manage moderate to severe pain. This powerful combination medication can offer significant relief, but its cost can sometimes be a barrier. At TheDrugClub, we're dedicated to helping our members access essential medications like hydrocodone acetaminophen more affordably through our prescription savings program.

Hydrocodone acetaminophen is a prescription medication primarily used for the short-term management of moderate to severe pain. It's often prescribed after injuries, surgeries, or for chronic conditions where other pain relievers haven't been sufficient. This medication is not typically used for mild pain, as it contains potent ingredients. It aims to reduce discomfort and improve a patient's quality of

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Hydrocodone-Acetaminophen is approved for (FDA label)

Hydrocodone bitartrate and acetaminophen oral solution is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy [see WARNINGS ], reserve opioid analgesics, including hydrocodone bitartrate and acetaminophen oral solution, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.

Source: Read the full FDA label on DailyMed. Label effective date: July 28, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Boxed warning for Hydrocodone-Acetaminophen (FDA label)

WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF HYDROCODONE BITARTRATE AND ACETAMINOPHEN ORAL SOLUTION Risk of Medication Errors Ensure accuracy when prescribing, dispensing, and administering hydrocodone bitartrate and acetaminophen oral solution 10 mg/300 mg per 15 mL. Dosing errors due to confusion between mg and mL, and other hydrocodone bitartrate and acetaminophen oral solutions of different concentrations can result in accidental overdose and death [see WARNINGS , DOSAGE AND ADMINISTRATION ]. Addiction, Abuse, and Misuse Because the use of hydrocodone bitartrate and acetaminophen oral solution exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death, assess each patient’s risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions [see WARNINGS ]. Life-Threatening Respiratory Depression Serious, life-threatening, or fatal respiratory depression may occur with use of hydrocodone bitartrate and acetaminophen oral solution, especially during initiation or following a dosage increase.

Source: FDA prescribing information (DailyMed). Set ID: 995a6cc7-8b72-4d35-b3b4-8c5752438fb7. SPL document ID: 57aeae78-a9f1-b224-e063-6394a90a4830. Label effective date: July 28, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Hydrocodone-Acetaminophen (FDA label)

The following adverse reactions have been identified during post approval use of hydrocodone bitartrate and acetaminophen oral solution. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. The most frequently reported adverse reactions are light-headedness, dizziness, sedation, nausea and vomiting. Other adverse reactions include: Cardio-Renal: Bradycardia, cardiac arrest, circulatory collapse, renal toxicity, renal tubular necrosis, hypotension. Central Nervous System/Psychiatric: Anxiety, dizziness, drowsiness, dysphoria, euphoria, fear, general malaise, impairment of mental and physical performance, lethargy, lightheadedness, mental clouding, mood changes, psychological dependence, sedation, somnolence progressing to stupor or coma. Endocrine: Hypoglycemic coma.

Source: FDA prescribing information (DailyMed). Set ID: 995a6cc7-8b72-4d35-b3b4-8c5752438fb7. SPL document ID: 57aeae78-a9f1-b224-e063-6394a90a4830. Label effective date: July 28, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Hydrocodone-Acetaminophen (FDA label)

Hydrocodone bitartrate and acetaminophen oral solution is contraindicated in patients with: Significant respiratory depression [see WARNINGS ] Acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see WARNINGS ] Known or suspected gastrointestinal obstruction, including paralytic ileus [see WARNINGS ] Hypersensitivity to hydrocodone or acetaminophen (e.g., anaphylaxis) [see WARNINGS , ADVERSE REACTIONS ]

Source: FDA prescribing information (DailyMed). Set ID: 995a6cc7-8b72-4d35-b3b4-8c5752438fb7. SPL document ID: 57aeae78-a9f1-b224-e063-6394a90a4830. Label effective date: July 28, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.